切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2023, Vol. 17 ›› Issue (06) : 395 -399. doi: 10.3877/cma.j.issn.1674-1358.2023.06.007

综述

人类免疫缺陷病毒感染/获得性免疫缺陷综合征患者非感染性相关眼病研究进展
陈珂1, 孙挥宇1,()   
  1. 1. 100015 北京,首都医科大学附属北京地坛医院五官科
  • 收稿日期:2023-06-10 出版日期:2023-12-15
  • 通信作者: 孙挥宇

Progress on non-infection-related eye diseases of patients with human immunodeficiency virus/acquired immune deficiency syndrome

Ke Chen1, Huiyu Sun1,()   

  1. 1. Ophthalmology and Otorhinolaryngology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
  • Received:2023-06-10 Published:2023-12-15
  • Corresponding author: Huiyu Sun
引用本文:

陈珂, 孙挥宇. 人类免疫缺陷病毒感染/获得性免疫缺陷综合征患者非感染性相关眼病研究进展[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(06): 395-399.

Ke Chen, Huiyu Sun. Progress on non-infection-related eye diseases of patients with human immunodeficiency virus/acquired immune deficiency syndrome[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(06): 395-399.

获得性免疫缺陷综合征(AIDS)是由人类免疫缺陷病毒(HIV)感染所致,可影响人体多个系统,进而导致不容忽视的健康问题。HIV/AIDS患者常见的眼部疾病会造成视力下降、视野缺失,甚至双目盲视,影响患者的日常生活。HIV/AIDS相关眼病表现广泛,包括血管病变、肿瘤、神经眼科疾病、免疫重建炎性综合征、药物不良反应以及非AIDS定义性眼病等,本文针对HIV/AIDS非感染相关性眼部疾病的研究进展进行综述。

Acquired immune deficiency syndrome (AIDS) is caused by human immunodeficiency virus (HIV), which affects multiple systems and can lead to health problems that cannot be ignored. Common eye diseases in HIV/AIDS patients may cause vision loss, visual field loss and possibly binocular blindness, affecting the quality of daily life of patients. HIV/AIDS-related eye diseases have a wide range of manifestations, including vascular diseases, tumors, neuro-ophthalmic diseases, immune reconstructive inflammatory syndrome, adverse drug reactions, and non-AIDS-defined eye diseases, etc. This article reviews non-infection-related eye diseases of HIV/AIDS patients.

[1]
Saini N, Hasjia S, Kaur P, et al. Study of prevalence of ocular manifestations in HIV positive patients[J]. Nepal J Ophthalmol,2019, 11(21):11-18.
[2]
World Health Organization. HIV and AIDS[EB/OL].

URL    
[3]
Lo PF, Lim R, Antonakis SN, et al. Progressive outer retinal necrosis: manifestation of human immunodeficiency virus infection[J]. BMJ Case Rep,2015:bcr2014207344.
[4]
吴苑妮, 张健, 宋心成, 等. 人类免疫缺陷病毒/获得性免疫缺陷综合征相关性眼病的研究进展[J/CD]. 中华实验和临床感染病杂志(电子版),2020,14(2):93-98.
[5]
Chen C, Guo CG, Meng L, et al. Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome[J]. Int J Ophthalmol, 2017,10(9):1396-1401.
[6]
Li LJ, Tan P, Hee O, et al. Brief report: retinal microvasculature and immune restoration among South Eastern Asian patients with HIV/AIDS over a 9-month antiretroviral therapy[J]. J Acquir Immune Defic Syndr,2022,90(2):170-174.
[7]
Jabs DA, Van Natta ML, Pak JW, et al. Association of retinal vascular caliber and age-related macular degeneration in patients with the acquired immunodeficiency syndrome[J]. Invest Ophthalmol Vis Sci,2018,59(2):904-908.
[8]
Tounouga DN, Kouotou EA, Nansseu JR, et al. Epidemiological and clinical patterns of Kaposi sarcoma: A 16-year retrospective cross-sectional study from Yaoundé, Cameroon[J]. Dermatology, 2018,234(5-6):198-204.
[9]
Radu O, Pantanowitz L. Kaposi sarcoma[J]. Arch Pathol Lab Med,2013,137(2):289-294.
[10]
Venkateswaran N, Ramos JC, Cohen AK, et al. Spotlight on ocular Kaposi’s sarcoma: an update on the presentation, diagnosis, and management options[J]. Expert Rev Ophthalmol,2021,16(6):477-489.
[11]
Donovan C, Patel H, Shetty S, et al. Aggressive conjunctival Kaposi sarcoma as the initial manifestation of acquired immunodeficiency syndrome[J]. Am J Ophthalmol Case Rep,2020,19(16):100832.
[12]
Re A, Cattaneo C, Rossi G. HIV and lymphoma: from Epidemiology to Clinical Management[J]. Mediterr J Hematol Infect Dis,2019,11(1):e2019004.
[13]
Vaccher E, Gloghini A, Carbone A. HIV-related lymphomas[J]. Curr Opin Oncol,2022,34(5):439-445.
[14]
Berhan A, Bayleyegn B, Getaneh Z. HIV/AIDS associated lymphoma: review[J]. Blood Lymphat Cancer,2022,12(29):31-45.
[15]
Steffen J, Coupland SE, Smith JR. Primary vitreoretinal lymphoma in HIV infection[J]. Ocul Immunol Inflamm,2021,29(3):621-627.
[16]
鲁丹, 孙挥宇, 毛菲菲, 等. HIV感染合并原发性眼眶淋巴瘤二例[J]. 眼科,2019,28(4):258-259.
[17]
Nanji AA, Mercado C, Galor C, et al. Updates in ocular surface tumor diagnostics[J]. Int Ophthalmol Clin,2017,57(3):47-62.
[18]
Henry RK, Bagg A, Wu C, et al. Orbital and ocular adnexal manifestations of adult T-cell leukemia/lymphoma: a case report and systematic review[J]. Ophthalmic Plast Reconstr Surg,2021,37(3):201-211.
[19]
Di Y, Xu HY, Ye JJ, et al. Clinical features and treatment outcomes of intraocular lymphoma: a single-center experience in China[J]. Int J Ophthalmol,2021,14(4):574-581.
[20]
鲁丹, 王胜男, 毛菲菲, 等. HIV/AIDS患者合并眼部肿瘤的临床特征分析[J]. 眼科,2021,30(6):474-476.
[21]
Gordon LK, Danesh-Meyer H. Neuro-ophthalmic manifestations of HIV infection[J]. Ocul Immunol Inflamm,2020,28(7):1085-1093.
[22]
Sudharshan S, Nair N, Curi A, et al. Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy--An update[J]. Indian J Ophthalmol,2020,68(9):1787-1798.
[23]
Sadik, MT, Aksu Ceylan N, Cebeci Z, et al. Patterns of cytomegalovirus retinitis at a tertiary referral center in Turkey[J]. Int Ophthalmol,2021,41(9):2981-2992.
[24]
Liu Q, Xu ZY, Wang XL, et al. Changes in conjunctival microbiota associated with HIV infection and antiretroviral therapy[J]. Invest Ophthalmol Vis Sci,2021,62(12):1.
[25]
Qian Y, Wang L, Jiang J, et al. Cytomegalovirus-immune recovery retinitis after initiation of highly active antiretroviral Therapy: A Case Series[J]. Front Med,2022,9(27):807013.
[26]
Han Y, Wu N, Zhu W, et al. Detection of HIV-1 viruses in tears of patients even under long-term HAART[J]. AIDS,2011,25(15):1925-1927.
[27]
Di Y, Zhao XY, Ye JJ, et al. Fundus manifestations and HIV viral loads of AIDS patients before and after HAART[J]. Int J Ophthalmol, 2019,12(9):1438-1443.
[28]
Qian Y, Wu Z, Chen C, et al. Detection of HIV-1 viral load in tears of HIV/AIDS patients[J]. Infection,2020,48(6):929-933.
[29]
毛菲菲, 孙挥宇, 李丹, 等. 获得性免疫缺陷综合征合并人类免疫缺陷病毒视网膜病变的眼底病变特征分析[J]. 中华眼底病杂志,2012,28(6):585-587.
[30]
Fisher KM, Montrief T, Ramzy M, et al. Cryptococcal meningitis: a review for emergency clinicians[J]. Intern Emerg Med,2021,16(4):1031-1042.
[31]
Nallu R, Madhavan P, Chirch L, et al. Thyroid eye disease due to immune reconstitution inflammatory syndrome as a consequence of antiretroviral therapy in the setting of AIDS[J]. Case Rep Endocrinol, 2020,2020:1728423.
[32]
Jin KW, Lee JY, Rhiu S, et al. Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy[J]. PLoS One,2019,14(4):e0215297.
[33]
Ando T, Kage H, Matsumoto Y, et al. Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease[J]. Respir Investig,2021,59(6):777-782.
[34]
Chuwongwattana S, Jantararoungtong T, Prommas S, et al. Impact of CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole in Thai patients with invasive fungal infections[J]. Pharmacol Res Perspect,2020,8(6):e00665.
[35]
Orssaud C, Guillemain R, Lillo Le Louet A. Toxic optic neuropathy due to voriconazole: possible potentiation by reduction of CYP2C19 activity[J]. European Rev Med Pharmacol Sci,2021,25(24):7823-7828.
[36]
Testi I, Agarwal A, Agrawal R, et al. Drug-induced uveitis in HIV patients with ocular opportunistic infections[J]. Ocul Immunol Inflamm,2020,28(7),1069-1075.
[37]
Sereti I, Altfeld M. Immune activation and HIV: an enduring relationship[J]. Curr Opin HIV AIDS,2016,11(2):129-130.
[38]
Singalavanija T, Ausayakhun S, Tangmonkongvoragul C. Anterior segment and external ocular disorders associated with HIV infections in the era of HAART in Chiang Mai University Hospital, a prospective descriptive cross sectional study[J]. PLoS One,2018,13(2):e0193161.
[1] 吴茜, 邓力, 练士贤, 张华, 江颖, 张宏伟. 伴人类免疫缺陷病毒感染乳腺癌患者的临床病理特征与预后的相关性研究[J]. 中华乳腺病杂志(电子版), 2023, 17(03): 151-156.
[2] 李春静, 张明帅, 彭卫, 付晓莹, 刘雪珍, 曹春燕, 任雅坤, 李洪娟, 赖丽思, 郑维. 巨大乳腺癌伴人免疫缺陷病毒感染一例[J]. 中华乳腺病杂志(电子版), 2022, 16(05): 319-321.
[3] 张玉, 薛文瑞, 王鑫, 李旭瑜, 王旭东, 袁鹏飞, 梁雨润, 韩志兴, 张海建, 刘庆军, 纪世琪. 人类免疫缺陷病毒感染合并膀胱癌14例临床特点[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 354-358.
[4] 吴令杰, 陈瑞烈, 陈桂佳, 肖湘明, 林钟滨. 两例获得性免疫缺陷综合征合并新型冠状病毒感染者抗病毒治疗并文献复习[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(04): 282-286.
[5] 李玉静, 陈七一, 谢汝明, 陈步东. 获得性免疫缺陷综合征相关原发性中枢神经系统淋巴瘤的预后研究[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(03): 200-208.
[6] 朱晓红, 周诗梦, 朱晓霞, 邹美银. 壳聚糖修饰的聚乳酸-羟基乙酸共聚物纳米颗粒在控制释放抗人类免疫缺陷病毒药物传递中的应用[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 125-132.
[7] 崔贵香, 丁晓燕, 褚盈晖, 孙代, 吴海燕, 陈京龙. 57例人类免疫缺陷病毒感染合并Burkkit淋巴瘤患者的临床分析[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 102-109.
[8] 袁瑞, 胡文佳, 桂希恩, 严亚军, 冯玲, 柯亨宁, 熊勇, 杨蓉蓉. 淋巴细胞精细分型检测在人类免疫缺陷病毒感染者/获得性免疫缺陷综合征患者中的应用[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 84-91.
[9] 王彤彤, 朱春雨, 刘颖楚, 郜桂菊. 复方磺胺甲噁唑治疗获得性免疫缺陷综合征合并肺孢子菌肺炎现状及其肝功能损伤机制[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 79-83.
[10] 王延雪, 胡虹英, 李新刚, 鹿星梦. 获得性免疫缺陷综合征患者免疫重建炎症综合征相关Graves’病5例并文献复习[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(01): 65-70.
[11] 李倩, 邓莉平, 陈果, 张忠威, 莫平征, 胡文佳, 陈良君, 张捷, 张永喜, 杨蓉蓉, 熊勇. 宏基因组二代测序在获得性免疫缺陷综合征合并中枢神经系统感染中的临床应用[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(01): 24-31.
[12] 汤艳芬, 赵雯, 马成杰, 刘刚, 陈奇, 刘菁, 薛天娇, 刘岩岩, 陈融佥, 王宇. 人类免疫缺陷病毒感染合并鸟分枝杆菌复合群病临床特点[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(05): 348-353.
[13] 董愉, 柳月红, 许雪静, 刘彬彬. 免散瞳超广角激光扫描检眼镜在获得性免疫缺陷综合征患者眼底病筛查中的优势[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(05): 344-347.
[14] 张燕珍, 王锡携, 文小兰. 血清巨噬细胞迁移抑制因子对活动性肺结核分诊检测的意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 200-202.
[15] 王希岗, 张波, 李鸣, 高敏, 薛建新. 神经外科手术部位感染在HIV感染者与非HIV感染者中的临床差异[J]. 中华神经创伤外科电子杂志, 2023, 09(04): 228-233.
阅读次数
全文


摘要